Home > HepCare Ireland—a service innovation project.

Connolly, Stephen P and Avramovic, Gordana and Cullen, Walter and McHugh, Tina and O'Connor, Eileen and McCombe, Geoff and Crowley, Des and Naughton, Anna Marie and Horan, Aidan and Lambert, John S (2021) HepCare Ireland—a service innovation project. Irish Journal of Medical Science, 190, pp. 587-595. https://doi.org/10.1007/s11845-020-02324-1.

Hepatitis C virus (HCV) remains a major cause of morbidity and death worldwide, with prevalence highest among people who inject drugs (PWID), homeless populations and prisoners. The World Health Organization has published targets to be achieved by 2030 as part of its global health sector strategy to eliminate viral hepatitis. Recent innovations in testing and treatment of HCV mean such goals are achievable with effective infrastructure, political will and funding. ‘HepCare Europe’ was a 3-year, EU-funded project involving four member states. It sought to develop, implement and evaluate interventions to improve HCV outcomes through multiple-level interventions, running between 2016 and 2019.


This paper aims to summarize the methods and present the aggregate cascade of care figures for the Irish components of HepCare. ‘HepCare Ireland’ contained five integrated work packages: HepCheck, HepLink, HepFriend, HepEd and HepCost.


Interventions included intensified screening, community-based assessment, linkage to specialist care, peer training and support, multidisciplinary educational resources and cost-effectiveness analysis. A total of 812 participants were recruited across the three clinical work packages in Ireland. Two hundred and fifty-seven (31.7%) of the tested participants had an HCV antibody-positive result, with 162 (63.0%) testing positive for HCV RNA. At the time of writing (6th of November 2019), 57 (54.8%) of participants put on treatment had achieved SVR12, with 44 (42.3%) still undergoing treatment.


In HepCheck, HepLink. HepEd and HepFriend, we demonstrate a series of interventions to improve Irish HCV outcomes. Our findings highlight the benefits of multilevel interventions in HCV care.

Item Type
Publication Type
Irish-related, Article
Drug Type
All substances
Identification #
Page Range
pp. 587-595
Related (external) link

Click here to request a copy of this literature

Repository Staff Only: item control page